Gonadotrophin heterogeneity and biopotency: Implications for assisted reproduction

Molecular Human Reproduction

Volumn 4, Issue 7, 1998, Pages 619-629

  Lambert, A ^a   Talbot, J A ^a   Anobile, C J ^a   Robertson, W R ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

Follicle stimulating hormone; Glycoprotein; Gonadotrophin; Luteinizing hormone

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN; GONADOTROPIN; LUTEINIZING HORMONE; RECOMBINANT FOLLITROPIN; RECOMBINANT HORMONE; TESTOSTERONE;

ARTICLE; CARBOHYDRATE ANALYSIS; HORMONAL REGULATION; HORMONE DETERMINATION; HUMAN; INFERTILITY THERAPY; METABOLIC REGULATION; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SIGNAL TRANSDUCTION;

ANIMALS; GLYCOSYLATION; GONADOTROPINS; HALF-LIFE; HUMANS; REPRODUCTIVE TECHNIQUES; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0031828231     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/4.7.619     Document Type: Article

References (122)

1. Allgeier, A., Laugwitz, K.L., Vansande, J. et al. (1997) Multiple G-protein coupling of the dog thyrotrophin receptor. Mol. Cell. Endocr., 127, 81-90.
2. Anobile, C.J., Talbot, J.A., McCann, S.J et al. (1998) Glycoform composition of serum gonadotrophins through the normal menstrual cycle and in the post-menopausal state. Mol. Hum. Reprod., 4, in press.
3. Arey, B.J., Stevis, P.E., Deecher, D.C. et al. (1997) Induction of promiscuous g protein coupling of the follicle stimulating hormone (FSH) receptor a novel mechanism for transducing pleiotropic actions of FSH isoforms. Mol. Endocrinol., 11, 517-526.
4. Baenziger, J.U. and Green, E.D. (1988) Pituitary glycoprotein hormone oligosaccharides: structure, synthesis and function of asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin. Biochim. Biophys. Acta, 947, 287-306.
5. Baird, D.T. (1996) Recent developments in gonadotrophins for clinical therapy. J. Endocrinol., 148, S38.
6. Balasch, J., Miro, F., Burzaco, I. et al. (1995) The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum. Reprod., 10, 1678-1683.
7. Beitins, I.Z. and Padmanabhan, V. (1991) Bioactive follicle -stimuating hormone. Trends Endocrinol. Metab., 2, 145-151.
8. Benmenahem, D. and Boime, I. (1996) Converting heterodimeric gonadotropins to genetically linked single chains - new approaches to structure-activity-relationships and analog design. Trends Endocrinol. Metab., 7, 100-105.
9. Bergh, C., Howles, C.M., Borg, K. et al. (1997) Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F®) versus highly purified urinary HSH (Metrodin HP®): results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum. Reprod., 12, 2133-2139.
10. Bidart, J.M., Puisicux, A., Troalen, F. et al. (1988) Characterisation of a cleavage product in the human chononic gonadotrophin beta subunit. Biochem. Biophys. Res. Comm., 154, 626-632.
11. Bishop, L.A., Nguyen T.V. and Schofield P.R. (1995) Both of the beta-subunit carbohydrate residues of follicle-stimulating-hormone determine the metabolic clearance rate and in-vivo potency. Endocrinology, 136, 2635-2640.
12. Buckler, H., Lambert, A., Anderson, A. and Robertson, W.R. (1998) Low dose alternate day recombinant FSH in an ovulation induction programme. Hum. Reprod., 13 (Abstr. Book 1), in press.
13. Burgon, P.G., Robertson, D.M., Stanton, P.G. and Hearn, M.T.W (1993) Immunological activities of highly purified isoforms of human FSH correlate with in vitro bioactivities. J. Endocrinol., 139, 511-518.
14. Burgon, P.G., Stanton P.G and Robertbon D.M. (1996) In-vivo bioactivities and clearance patterns of highly purified human luteinizing hormone isoforms. Endocrinology, 137, 4827-4836.
15. Campbell, R.K., Deanemig, D.M. and Moyle W.R. (1991) Conversion of human chonogonadotrophin into a follitropin by protein engineering Proc. Natl. Acad. Sci. USA, 88, 760-764.
16. Chappel, S.C. (1995). Heterogeneity of follicle stimulating hormone: control and physiological function. Hum. Reprod. Update, 1, 479-487.
17. Chappel, S.C. and Howles, C. (1991) Reevaluation of the roles of luteinizing hormone and follicle-stimulating hormone in the ovulatory process - review. Hum Reprod., 6, 1206-1212.
18. Chen, W. and Bahl, O.P (1992) Polyclonal antibodies against the polypeptide and carbohydrate epitopes of recombinant human choriogonadotropin beta-subunit. Mol Cell. Endocrinol., 86, 57-66.
19. ChristinMaitre, S., Taylor, A.E., Khoury, R.H. et al (1996) Homologous in-vitro bioassay for follicle-stimulating-hormone (FSH) reveals increased FSH biological signal during the mid-phase to late luteal-phase of the human menstrual-cycle. J. Clin Endocrinol. Metab., 81, 2080-2088.
20. Combarnous, Y. (1992) Molecular basis of the specificity of binding of glycoprotein hormones to their receptors. Endocr. Rev., 13, 670-691.
21. Creus, S., Pellizzan, E., Cigorraga, S B. and Campo, S. (1996) FSH isoforms: bio and immuno-activities in post-menopausal and normal menstruating women. Clin. Endocrinol , 44, 181-189.
22. Dahl, K.D. Bicsak, TA. and Hsueh A.J.W. (1988) Naturally occurring antihormones: secretion of antagonists by women treated with a GnRH analogue. Science, 239, 72-74.
23. De Leeuw, R , Mulders, J , Voortman, G. et al. (1996) Structure-function relationship of recombinant follicle stimulating hormone (Puregon). Mol. Hum. Reprod., 2, 361-369.
24. Demers, L.M. (1991) Monoclonal antibodies to lutropin: are our immunoassays too specific? Clin Chem., 37, 311-2.
25. Dharmesh, S. M. and Baenziger, J.U. (1993) Estrogen modulates expression of the glycosyltransferases that synthesize sulfated oligosaccharides on lutropin. Proc. Natl Acad Sci. USA, 90, 11127-11131.
26. Ding, Y.Q and Huhtaniemi, I. (1991) Preponderance of basic isoforms of serum luteinizing hormone (LH) is associated with the high bio/immuno ratio of LH in healthy women and in women with polycystic ovarian disease Hum Reprod., 6, 346-350.
27. Djerassi, A., Coutifaris, C., West, V.A. et al. (1995) Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating-hormone and causing ovarian hyperstimulation. J. Clin. Endocrinol. Metab., 80, 591-594.
28. Dunkel, L., Jia, X.C., Nishimori, K. et al. (1993) Deglycosylated human chorionic-gonadotrophin (HCG) antagonises HCG stimulation of 3′,5′-cyclic adenosine-monophosphate accumulation through a noncompetitive interaction with recombinant human luteinizing-hormone receptors. Endocrinology, 132, 763-769.
29. El-Deiry, S., Kaetzel, D. Kennedy, G. et al. (1989) Site directed mutagenesis of the human chorionic-gonadotrophin beta-subunit bioactivity of a heterologous hormone, bovine alpha-human des-(122-145)-beta .Mol. Endocrinol., 3, 1523-1528.
30. Emperaire, J.C. and Ruffie, A. (1991) Triggering ovulation with endogenous luteinizing hormone may prevent the ovarian hyperstimulation syndrome Hum.Reprod., 6, 506-510.
31. Eshkol, A. (1996) Recombinant gonadotrophins: an introduction. Hum. Reprod., 11 (Suppl. 1), 89-94.
32. Fares, F.A , Suganuma, N., Nishimori, K. et al. (1992) Design of a long-acting follitropin agonist by fusing the C-terminal sequence of the chorionic gonadotropin β subunit to follitropin β subunit. Proc. Natl. Acad. Sci. USA, 89, 4303-4308.
33. Fauser, B.C.J.M. and Van Heusden, A.M (1997) Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr. Rev., 18, 71-106.
34. Flack, M.R., Froelich, J., Bennet A.P et al. (1994) Site directed mutagenesis defines the individual roles of the glycosylation sites on follicle stimulating hormone. J. Biol. Chem., 269, 14015-14020
35. Furui, K., Suganuma, N., Tsukahara, S.-H. et al. (1994) Identification of two point mutations in the gene coding luteinizing hormone (LH) β-subunit, associated with immunologically anomalous LH variants J Clin. Endocrinol Metab., 78, 107-113.
36. Galway, A.B., Hsueh, A.J.W., Keene, J.L. et al. (1990) In-vitro and in-vivo bioactivity of recombinant human follicle-stimulating hormone and partially deglycosylated variants secreted by transfected eukaryotic cell lines. Endocrinology, 127, 93-100.
37. Gray, C.J. (1988) Glycoprotein gonadotrophins. Structure and synthesis. Acta Endocrinol., 288, 20-27.
38. Green, E.D. and Baenziger, J.U. (1988a) Asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin. Part I. J. Biol. Chem., 263, 25-35.
39. Green, E.D. and Baenziger, J.U. (1988b) Asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin. Part II. J. Biol. Chem., 263, 36-44.
40. Haavisto, A.M., Simberg, N. and Huhtaniemi, I. (1990) The bio/immuno ratio of serum luteinizing-hormone increases after orchidectomy in prostatic-cancer patients and is associated with decreased molecular-weight and appearance of isohormones with alkaline pl values. Biol. Reprod., 42, 597-602.
41. Harris, S.D , Anobile, C.J., McLoughlin, J. et al. (1996) Internal carbohydrate complexity of the oligosaccharide chains of recombinant human follicle stimulating hormone (Puregon, ORG 32489); comparison with Metrodin and Metrodin HP. Mol Hum. Reprod., 2, 807-811.
42. Harris, S.D., Lambert, A. and Robertson W.R. (1998a) In-vitro biopotency of two glycoform fractions of differing acidity and of two deglycosylated variants. IFFS/American Society for Reproductive Medicine (Abstr. Book), in press
43. Harris, S D., Lambert, A. and Robertson W.R. (1998b) In-vitro biopotency of two glycoform mixtures of differing acidity derived from recombinant FSH measured using a human granulosa-lutein cell bioassay. Hum. Reprod., 13 (Abstr. Book 1), in press.
44. Harsch, I. A., Simoni, M. and Nieschlag, E. (1993) Molecular heterogeneity of serum follicle-stimulating-hormone in hypogonadal patients before and during androgen replacement therapy and in normal men. Clin. Endocrinol., 39, 173-180.
45. Heseltine, D., White, M.C., Kendall-Taylor, P. et al. (1989) Testicular enlargement and elevated serum inhibin concentrations occur in patients with pituitary macroadenomas secreting follicle-stimulating hormone. Clin. Endocrinol., 31, 411-423.
46. Horsman, G , Talbot, J.A., McLoughlin, J.D. et al. (1998) A biological, immunological, and physico-chemical comparison of Gonal-F and Puregon. Hum. Reprod., 13 (Abstr. Book 1), in press.
47. Hull, M., Corrigan, E., Piazzi, A. and Loumaye, E. (1994) Recombinant human luteinising hormone: an effective new gonadotropin preparation. Lancet, 344, 334-335.
48. Imthurn, B., Piazzi, A. and Loumaye, E. (1996) Recombinant human luteinising hormone to mimic mid-cycle LH surge. Lancet, 348, 332-333.
49. Jeffcoate, S.L. (1993) Analytical and clinical significance of peptide hormone heterogeneity with particular reference to growth hormone and luteinizing hormone in serum. Clin. Endocrinol., 38, 113-21.
50. Jeffcoate, S.L. (1997) Standardization of human follicle-stimulating hormone for therapy and diagnosis. Report of an International Workshop, National Institute of Biological Standards and Control, UK, 27-22 March, 1996.
51. 397 is important for receptor activation. J. Biol. Chem., 268, 20851-20854.
52. Ji, I. and Ji, T.H. (1995) Differential roles of exoloop 1 of the human follicle stimulating hormone receptor in hormone binding and receptor activation. J. Biol. Chem., 270, 15970-15973.
53. Jia, X.C. and Hsueh, A.J.W. (1986) Granulosa cell aromatase bioassay for follicle-stimulating hormone: validation and application of the method. Endocrinology, 119, 1570-1577.
54. Kousta, E., White, D.M., Piazzi, A et al. (1996) Successful induction ovulation and completed pregnancy using recombinant human luteinizing hormone and follicle stimulating hormone in a woman with Kallmann's syndrome. Hum. Reprod., 11, 70-71.
55. Kula, K., Petterson, T.M., vanSantbrink, J.B. et al. (1997) Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. Fertil. Steril., 67, 998-1004.
56. Lambert, A., Rodgers, M., Mitchell, R. et al. (1995) In-vitro biopotency and glycoform distribution of recombinant human FSH (ORG32489), Metrodin and Metrodin-HP. Hum. Reprod., 10, 1928-1935
57. Lapolt, P.S., Nishimon, K., Fares, FA. et al. (1992) Enhanced stimulation of follicle maturation and ovulatory potential by long acting follicle-stimulating hormone agonists with extended carboxyl-terminal peptides. Endocrinology, 131, 2514-2520.
58. Lapthorn, A.J., Harris, D.C., Littlejohn J. et al. (1994) Crystal structure of human chorionic gonadotrophin. Nature, 369, 455-461.
59. le Cotonnec, J.Y., Porchet, H.C , Beltrami, V. and Howles, C. (1993) Comparative pharmacokinetics of two urinary human follicle stimulating hormone preparations in healthy female and male volunteers. Hum. Reprod., 8, 1604-1611.
60. Loumaye, E., Martineau I., Piazzi A. et al. (1996) Clinical-assessment of human gonadotropins produced by recombinant DNA technology. Hum. Reprod., 11 (Suppl. 1), 95-107.
61. Marshall, J.C. and Griffin, M L. (1993) The role of changing pulse frequency in the regulation of ovulation. Hum. Reprod , 8, 57-61.
62. Mason, M., Fonseca, E., Ruiz, J.E. et al. (1992) Distribution of follicle-stimulating-hormone and luteinizing-hormone isoforms in sera from women with primary ovarian failure compared with that of normal reproductive and postmenopausal women. Fertil Steril., 58, 60-65.
63. Matzuk, M.M., Hsueh, A.J.W., Lapolt, P. et al. (1990) The biological role of the carboxyl-terminal extension of human chorionic gonadotrophin beta subunit. Endocrinology, 126, 376-383.
64. Michael, A.E., Gregory, L., Piercy, E.C. et al. (1995) Ovarian 11β-hydroxysteroid dehydrogenase activity is inversely related to the outcome of in vitro fertilisation-embryo transfer treatment cycles. Fertil. Steril., 64, 590-598.
65. Mitchell, R., Bauerfeld, C., Schaefer, F. et al. (1994) Less acidic forms of LH are associated with lower testosterone secretion in normal men and men with chronic renal failure. Clin. Endocrinol., 41, 65-73.
66. Morrel, A.G., Gregoriadis, G., Scheinberg, I.H. et al. (1971) The role of sialic acid in determining the survival of glycoproteins in the circulation. J. Biol. Chem., 246, 1461-1467.
67. Nargund, G., Bourne, T., Doyle, P. et al. (1996a) Associations between follicular blood flow, oocyte recovery and preimplantation embryo quality. Hum Reprod., 11, 109-113.
68. Nargund, G., Doyle, P.E., Bourne, T.H. et al. (1996b) Ultrasound derived indices of follicular blood flow before HCG administration and the prediction of oocyte recovery and preimplantation embryo quality Hum. Reprod., 11, 2512-2517.
69. Nomura, K., Tsunasawa, S , Ohmura, K. et al. (1988) Renotropic activity in ovine luteinizing hormone isoform(s). Endocrinology, 123, 700-12
70. Nomura, K., Ohmura, K., Nakamura, Y. et al. (1989) Porcine luteinizing hormone isoform(s): relationship between their molecular structures, and renotropic versus gonadotropic activities. Endocrinology, 124, 712-9.
71. Out, H.J., Mannaerts, B.M., Driessen, S.G. and Bennink, H.J. (1995) A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum.Reprod., 10, 2534-2540.
72. Padmanabhan, V. (1995) Neuroendocrine control and physiologic relevance of FSH heterogeneity. J Reprod. Fertil. (Absr. Series), 15, Abs. S3.
73. Padmanabhan, V., Chappel, S.C. and Beitins, I.Z. (1987) An improved in vitro bioassay for follicle-stimulating hormone (FSH): suitable for measurement of FSH in unextracted human serum. Endocrinology, 121, 1089-1098.
74. Padmanabhan, V., Lang, L.L., Sonstein, J. et al. (1988) Modulation of follicle-stimulating hormone bioactivity and isoform distribution by estrogenic steroids in normal women and in gonadal dysgenesis. J. Clin. Endocrinol. Metab, 67, 465-473.
75. Papandreou, M.J., Asteria, C., Petterson, K. et al. (1993) Concanavalin A affinity chromatography of human serum gonadotrophins: evidence for changes in carbohydrate structure in different clinical conditions. J. Clin. Endocrinol. Metab., 76, 1008-1013.
76. Perez, G.T. and Apfelbaum, M.E. (1996) GnRH-stimulated glycosylation (proximal and distal) of luteinizing hormone by cultured rat pituitary cells. Neuroendocrinology, 64, 456-461.
77. Pettersson, K., Ding, YQ. and Huhtaniemi, I. (1992) An immunologically anomalous luteinizing hormone variant in a healthy woman. J. Clin. Endocrinol. Metab., 74, 164-171
78. Pigny, P., Henric, B., Lahlou, N. et al. (1996) A gonadotroph adenoma with a high proportion of basic FSH isoforms by chromatofocusing. J. Clin. Endocrinol. Metab., 81, 2407-2408.
79. Porchet, H.C , Le Cotonnec, J-Y., Neuteboom, B. et al. (1995) Pharmacokineties of recombinant human luteinizing hormone after intravenous, intramuscular, and subcutaneous administration in monkeys and comparison with intravenous administration of pituitary human luteinizing hormone. J. Clin. Endocrinol. Metab., 80, 667-673.
80. Prestoz, L.L C., Couto, A.S., Shin, Y S. and Petry, K.G. (1997) Altered follicle stimulating hormone isoforms in female galactosaemia patients. Eur. J. Pediat., 156, 116-120.
81. Recombinant Human FSH Study Group (1995) Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization. Fertil. Steril., 63, 77-86.
82. Regan, L., Owen, E.J and Jacobs, H.S. (1990) Hypersecretion of luteinising hormone, infertility and miscarriage. Lancet, 336, 1141-1144.
83. Robertson, W.R. (1997a) Carbohydrate sidechains and FSH biopotency: Implications for ART. In Jones, H.W. and Lunenfeld, B. (eds), Evolution in Ovulation Induction and ART. New Treatment Modalities for the Next Millenium. Medical Education Collaborative, Golden, CO, USA, pp. 30-34.
84. Robertson, W.R. (1997b) Gonadotrophin isoform pattern in different pharmaceutical preparations. In Kahn, J.A. (ed.), Gonadotrophin Isoforms Facts and Future. Serono Fertility Series. Vol. 2. Ciconia Foundation, Copenhagen, Denmark, pp. 53-60.
85. Robertson, W.R., Lambert, A., Mitchell, R. and Talbot, J.A. (1997) In Fauser, B.J.C.M., Coelingh Bennink, J.L.H Evers, R. et al. (eds), FSH Action and Intraovarian Regulation. Parthenon Press, Carnforth, UK.
86. Rodgers, M , Mitchell, R., Lambert, A. et al. (1992) Human chorionic gonadotrophin contributes to the bioactivity of Pergonal. Clin. Endocrinol., 37, 558-564.
87. Rodgers, M., McLoughlin, J.D., Lambert, A. et al. (1995) Variability in the immunoreactive and bioactive follicle stimulating hormone content of human urinary menopausal gonadotrophin preparations. Hum. Reprod., 10, 1982-1986.
88. Sairam, M.R. (1983) In Li, C.H. (ed.), Hormonal Proteins and Peptides: Gonadotrophic Hormones. Academic Press, New York, pp. 1-79.
89. Segaloff, D.L. and Ascoli, M. (1993) The lutropin/choriogonadotrophin receptor...4 years later. Endocr. Rev., 14, 324-347.
90. Shome, B., Parlow, A.F., Liu, W.K. et al. (1988) A reevaluation of the amino-acid sequence of the human follitropin beta-subunit. J. Protein Chem., 7, 325-339.
91. Siebold, B. (1996) Physicochemical characterization of recombinant human follicle stimulating hormone. Hum. Reprod., 11 (Suppl. 1), 109-115.
92. Simon, J.A., Danforth, D.R., Hutchison, J.S. and Hodgen, G.D. (1988) Characterization of recombinant DNA derived-human luteinizing hormone in vitro and in vivo. J. Am. Med. Assoc., 259, 3290-3295
93. Simoni, M., Jockenhovel, F., and Nieschlag, E. (1993) Biological and immunological properties of the international standard for FSH-83/575 - isoelectrofocusing profile and comparison with other FSH preparations. Acta Endocrinol., 128, 281-288.
94. Simoni, M., Jockenhovel, F. and Nieschlag, E. (1994) Polymorphism of human pituitary FSH: analysis of immunoreactivity and in vitro bioactivity of different molecular species. J. Endocrinol., 141, 359-367.
95. Smith, K.A., McConway, M.G , Perry, B. et al. (1992) Discrepancies in hFSH measurements by 2-site IRMA in the ovulatory phase of the menstrual cycle. Ann. Clin. Biochem., 29, 351-353.
96. Stanton, P.G., Shen, Z , Kecorius, E.A. et al. (1995) Application of a sensitive HPLC-based fluorimetric assay to determine the sialic acid content of human gonadotrophin isoforms. J. Biochem. Biophys. Meth., 30, 37-48.
97. Stockell-Hartree, A. and Renwick, A.G.C. (1992) Molecular structures of glycoprotein hormones and functions of their carbohydrate components. Biochem. J., 287, 665-679.
98. Stockell-Hartree, A. and Shownkeen, R.C. (1991) Studies of human pituitary LH containing internally cleaved beta-subunit. J. Mol. Endocr., 6, 101-109.
99. Storring, P.L. (1992) Assaying glycoprotein hormones - influence of glycosylation on immunoreactivity Trends Biotechnol, 10, 427-431.
100. Sugahara, T., Pixley M.R., Minami, S. et al. (1995) Biosynthesis of a biologically active single peptide chain containing the human common α and chorionic gonadotrophin β subunits in tandem. Proc. Natl. Acad Sci. USA, 92, 2041-2045.
101. Sugahara, T., Sato, A , Kudo, M. et al. (1996) Expression of biologically-active fusion genes encoding the common alpha-subunit and the follicle-stimulating-hormone beta-subunit - role of a linker sequence. J. Biol. Chem., 271, 10445-10448.
102. Talbot, J.A., Mitchell, R., Hoy, A.M et al. (1996) Recombinant human luteinising hormone (rhLH): a partial physico-chemical, biological and immunological characterisation. Mol. Hum. Reprod. 2, 799-806.
103. Tano, M., Minegishi, T., Nakamura, K et al. (1995) Application of chinese-hamster ovary cells transfected with the recombinant human follicle-stimulating-hormone (FSH) receptor for measurement of serum FSH. Fertil Steril., 64, 1120-1124.
104. Themmen, A P.N., Martens, J.W.M. and Brunner, H.G. (1997) Gonadotrophin receptor mutations. J. Endocrinol., 153, 179-183.
105. Toledo, S.P A., Brunner, H.G., Kraaij, R. et al. (1996) An inactivating mutation of the luteinizing-hormone receptor causes amenorrhea in a 46,xx female. J. Clin. Endocrinol. Metab., 81, 3850-3854.
106. Tsatsoulis, A., Shalet, S.M and Robertson W.R. (1991) Bioactive gonadotrophin secretion in man. Clin. Endocrinol., 35, 193-206.
107. Ujihari, M., Nomura, K., Toraya, S. and Demura, H. (1990) Uninephrectomy inducing quantitative and qualitative changes in LH isoforms in the male rat. Acta Endocrinol., 123, 365-70.
108. Ulloa-Aguirre, A., Craviato, A., Damian-Matsumara, P. et al. (1992) Biological characterization of the naturally occurring analogues of intrapituitary human follicle-stimulating hormone. Hum. Reprod., 7, 23-30.
109. Ulloa-Aguirre, A., Espinoza, R., Damian-Matsumura, P. and Chappel, S.C. (1988) Immunological and biological potencies of the different molecular species of gonadotrophins. Hum. Reprod., 3, 491-501.
110. Ulloa-Aguirre, A., Midgley, A.R. Jr., Beitins, I.Z. and Padmanabhan, V. (1995) Follicle-stimulating isohormones: characterization and physiological relevance. Endocr. Rev., 16, 765-787.
111. Valove, F.M., Finch, C., Anasti, J.N. et al. (1994) Receptor binding and signal transduction are dissociable functions requiring different sites on follicle-stimulating hormone. Endocrinology, 135, 2657-2661.
112. Vitt, U.A., Kloosterboer, H.J., Rose, U.M. et al. (1997) Differential effects of 3 hFSH isohormones on ovarian follicle development in vitro. J. Reprod. Fertil., 20. [Abstr. no. 22].
113. Westwood, M., Gibson, J.M., Davies, A.J. et al. (1994) The phosphorylation pattern of insulin-like growth factor-binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J. Clin. Endocr. Metab., 79, 1735-1741.
114. Wide, L. and Bakos, O. (1993) More basic forms of both human follicle-stimulating hormone and luteinizing hormone at mid-cycle compared with the follicular and luteal phase. J. Clin. Endocrinol. Metab., 76, 885-889.
115. Wide, L. and Naessen, T. (1994) 17β-oestradiol counteracts the formation of the more acidic isoforms of follicle-stimulating hormone and luteinizing hormone after menopause. Clin. Endocrinol., 40, 783-789.
116. Wide, L., Naessen, T., Eriksson, K. and Rune, C. (1996) Time-related effects of a progestogen on the isoforms of serum gonadotropins in 17-beta-estradiol treated postmenopausal women. Clin. Endocrinol., 44, 651-658.
117. Wide, L., Naessen, T. and Phillips, D.J. (1995) Effect of chronic daily oral administration of 17β-oestradiol and norethisterone on the isoforms of serum gonadotrophins in post menopausal women. Clin Endocrinol., 42, 59-64.
118. Wikland, M., Borg, J., Hamberger, L. and Svalander, P. (1994) Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction. Hum. Reprod., 9, 1430-1436.
119. Wilson, C.A., Leigh, A.J. and Chapman, A.J. (1990) Gonadotrophin glycosylation and function. J. Endocrinol., 125, 3-14.
120. Zambrano, E., de Tomasi, B., Cardenas, M. and Ulloa-Aguirre, A. (1996) Studies on the relative in-vitro biological potency of the naturally-occurring isoforms of intrapituitary follicle stimulating hormone. Mol. Hum. Reprod , 2, 563-571.
121. Zambrano, E., Olivares, A., Pablo Mendez, J. et al. (1995) Dynamics of basal and gonadotrophin-releasing-hormone-releasable serum follicle stimulating hormone charge isoform distribution throughout the menstrual cycle. J. Clin. Endocrinol. Metab., 80, 1647-1656.
122. Zeng, H.W., Ji, I.H. and Ji, T.H. (1995) Lys (91) and his (90) of the alpha subunit are crucial for receptor-binding and hormone action of follicle stimulating hormone (FSH) and play hormone-specific roles in FSH and human chorionic-gonadotrophin. Endocrinology, 136, 2948-2953.